News Muncher - searching for vaccinated

1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

India Approved Dcgi Dose Covishield Covovax

2 years, 7 months ago

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids

News 18

In the wake of schools reporting a spike in coronavirus cases among children, the Drugs Controller General of India has approved the restricted emergency use of three vaccines for different age groups of children — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D. Covaxin has received the emergency use authorisation for the age group of 6 to 12 …

India Children Vaccination Age Vaccines Group Virus

2 years, 11 months ago

Coxavin gets DCGI nod for use among 12-18 age group

Hindustan Times

New Delhi The Drugs Controller General of India on Saturday approved Covaxin for use in children between the ages of 12 and 18, a significant step towards opening vaccinations to the age group that has so far remained ineligible in India’s immunisation programme against Covid-19. The approval from DCGI came nearly 10 weeks after the subject expert committee of the …

India Children Age Vaccine Dcgi

3 years, 2 months ago

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax

Live Mint

Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin. The company, meanwhile, has put in an application seeking the nod of the Drugs Controller General of India to conduct the …

India Vaccine Dcgi Clinical Biological E Covishield Corbevax

3 years, 6 months ago

No clinical trials required in India for global Covid vaccines: DCGI

India TV News

Globally available Covid 19 vaccines can now be launched in India without the requirement of post approval clinical trials and testing every batch of the vaccine. The Drugs Controller General of India in a notification has said that vaccines which have been approved for restricted use by US FDA, EMA, UK MHRA and PMDA Japan and under the WHO Emergency …

India Vaccines Vaccine

3 years, 6 months ago

DCGI eases norms for clearing foreign-made COVID-19 vaccines to bolster availability of shots

Firstpost

These exemptions have been made in light of the huge vaccination requirements in India in the wake of the recent surge of COVID-19 cases and the need for increased availability of imported vaccines to meet national requirements India’s apex drug regulator has waived the requirement of testing every batch of foreign-made COVID-19 vaccines by the Central Drugs Laboratory, Kasauli and …

India Vaccines Vaccine Dcgi Kasauli Requirement Imported Vaccines

3 years, 7 months ago

Will global tender for Covid-19 vaccines by states help?

India Today

About a dozen states have opted for floating global tenders to procure Covid-19 vaccines. Only three Covid-19 vaccines have been approved by the DCGI — Covishield, Covaxin and Sputnik V. Of these, Covishield-maker Serum Institute of India is the largest vaccine producer and is based in India. It is unlikely that AstraZeneca, which has a partner in India, will enter …

India Supply States Indian Vaccines Chinese Covid

3 years, 11 months ago

Politics drives India's fight against the COVID-19 pandemic even as questions over DCGI's approvals for vaccines persist

The Hindu

The Drug Controller General ofIndia’s rushed approval on January 3 for Restricted Emergency Use —also sometimes referred to as Emergency Use Authorisation —of two COVID-19 vaccines— Covishield of the Serum Institute of India, Pune, and Covaxin of Bharat Biotech, Hyderabad—has revealed once again that politics and not science continues to be in the driving seat in the fight against the …

India Safety Trial Data Trials Indian Vaccines

3 years, 11 months ago

Excitement in some, disappointment in others: A peek into Covaxin phase 3 trial centres

India Today

Three different cities, three different scenarios on Covaxin phase 3 trials! In Mumbai, doctors are finding it hard to convince people for the second dose; in Patna, more people have registered for clinical trials compared to phase 1 and phase 2; and in Jaipur, long lines of exuberant candidates are witnessed outside trial centres. 1,200 HUMAN TRIAL VOLUNTEERS AT PATNA …

India Mumbai Trial Candidates Trials Hospital Second

4 years, 3 months ago

Oxford vaccine: DCGI directs Serum Institute of India to suspend recruitment for trials